{"count":3,"next":null,"previous":null,"results":[{"gene_data":{"alias":["ADRARL1"],"biotype":null,"hgnc_id":"HGNC:282","gene_name":"adrenoceptor alpha 2B","omim_gene":["104260"],"alias_name":null,"gene_symbol":"ADRA2B","hgnc_symbol":"ADRA2B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:96778707-96781984","ensembl_id":"ENSG00000222040"}},"GRch38":{"90":{"location":"2:96112875-96116245","ensembl_id":"ENSG00000274286"}}},"hgnc_date_symbol_changed":"1990-09-10"},"entity_type":"gene","entity_name":"ADRA2B","confidence_level":"1","penetrance":null,"mode_of_pathogenicity":"Other - please provide details in the comments","publications":["21937992"],"evidence":["DD-Gene2Phenotype","Expert Review Red"],"phenotypes":["AUTOSOMAL RECESSIVE MENTAL RETARDATION"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":484,"hash_id":null,"name":"DDG2P","disease_group":"","disease_sub_group":"","status":"public","version":"1.137","version_created":"2019-10-08T15:56:59.220133Z","relevant_disorders":[],"stats":{"number_of_genes":1893,"number_of_strs":0,"number_of_regions":0},"types":[{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["ADRARL1"],"biotype":null,"hgnc_id":"HGNC:282","gene_name":"adrenoceptor alpha 2B","omim_gene":["104260"],"alias_name":null,"gene_symbol":"ADRA2B","hgnc_symbol":"ADRA2B","hgnc_release":"2017-11-03","ensembl_genes":{"GRch37":{"82":{"location":"2:96778707-96781984","ensembl_id":"ENSG00000222040"}},"GRch38":{"90":{"location":"2:96112875-96116245","ensembl_id":"ENSG00000274286"}}},"hgnc_date_symbol_changed":"1990-09-10"},"entity_type":"gene","entity_name":"ADRA2B","confidence_level":"2","penetrance":null,"mode_of_pathogenicity":"","publications":["11701600"],"evidence":["Expert Review Amber","NHS GMS","Wessex and West Midlands GLH"],"phenotypes":["Epilepsy, myoclonic, familial adult, 2, 607876"],"mode_of_inheritance":"MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","tags":[],"panel":{"id":402,"hash_id":null,"name":"Genetic epilepsy syndromes","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Inherited Epilepsy Syndromes","status":"public","version":"1.363","version_created":"2019-10-08T10:06:11.607307Z","relevant_disorders":["Epilepsy Plus","Epilepsy plus other features","Genetic Epilepsy Syndromes","Epileptic encephalopathy","Familial Focal Epilepsies","Familial Genetic Generalised Epilepsies","Genetic Epilepsies with Febrile Seizures Plus (GEFS+)","Genetic Epilepsies with Febrile Seizures Plus"],"stats":{"number_of_genes":614,"number_of_strs":2,"number_of_regions":13},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease","slug":"gms-rare-disease","description":"This panel type is used for GMS panels that are not virtual (i.e. could be a wet lab test)"},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}},{"gene_data":{"alias":["ADRARL1"],"biotype":null,"hgnc_id":"HGNC:282","gene_name":"adrenoceptor alpha 2B","omim_gene":["104260"],"alias_name":null,"gene_symbol":"ADRA2B","hgnc_symbol":"ADRA2B","hgnc_release":"2017-11-03T00:00:00","ensembl_genes":{"GRch37":{"82":{"location":"2:96778707-96781984","ensembl_id":"ENSG00000222040"}},"GRch38":{"90":{"location":"2:96112875-96116245","ensembl_id":"ENSG00000274286"}}},"hgnc_date_symbol_changed":"1990-09-10"},"entity_type":"gene","entity_name":"ADRA2B","confidence_level":"1","penetrance":"Complete","mode_of_pathogenicity":"","publications":["24114805","21937992"],"evidence":["Expert Review Red"],"phenotypes":["AUTOSOMAL RECESSIVE MENTAL RETARDATION"],"mode_of_inheritance":"BIALLELIC, autosomal or pseudoautosomal","tags":[],"panel":{"id":285,"hash_id":"558aa423bb5a16630e15b63c","name":"Intellectual disability","disease_group":"Neurology and neurodevelopmental disorders","disease_sub_group":"Neurodevelopmental disorders","status":"public","version":"2.1065","version_created":"2019-10-07T13:42:16.019766Z","relevant_disorders":["Coarse facial features including Coffin-Siris-like disorders","ID","Moderate","severe or profound intellectual disability","Schizophrenia plus additional features","Intellectual disability - microarray","fragile X and sequencing"],"stats":{"number_of_genes":2253,"number_of_strs":11,"number_of_regions":57},"types":[{"name":"Rare Disease 100K","slug":"rare-disease-100k","description":"Rare Disease 100K"},{"name":"GMS Rare Disease Virtual","slug":"gms-rare-disease-virtual","description":"This is a panel for the Genomic Medicine Service for an exome/genome/panel based test that requires a virtual gene panel for rare disease in the Test Directory."},{"name":"Component Of Super Panel","slug":"component-of-super-panel","description":"This panel is a component of a Super Panel"}]}}]}